/NAGE

Niagen Bioscience Inc

NAGE

$3.04USD↑+0.16%+0.00 today

MARKET CAP

240.5M

P/E (TTM)

19.0x

FWD P/E

32.3x

DAY RANGE

$3 – $3

52W RANGE

$3

$11

AI Summary

Stalk

Sell NowHigh

Given the decisive break below the 3.61 support with elevated volume and extended EMAs, the downtrend remains intact across all horizons. Long-term and medium-term biases are bearish. Short-term conditions favor execution now. We will sell into the breakdown, leveraging momentum continuation dynamics.

↑Q2 revenue reached $29.8 M (+2% YoY), Tru Niagen $24.2 M (+6%).
↑E-commerce sales grew 23% YoY to $20.5 M; 10–15% growth guide.
↓Stock volatility is extremely high, deterring risk-averse investors.

Full analysis →

Buying

2

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	4.18 M	13.35 M	+313.04 K	-21.8%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	674.81 K	2.15 M	+-3.47 K	-28.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	659.58 K	2.10 M	+-669.26 K	-64.1%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	472.06 K	1.51 M	+-559.28 K	-66.9%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	333.20 K	1.10 M	+6.49 K	-21.4%	0.00%
MM Millennium Management LLC Q2 2026	SELL	275.42 K	878.60 K	+-275.93 K	-63.9%	0.00%
JH Janus Henderson Group Plc Q1 2026	SELL	0.00	0.00	+-24.37 K	-100.0%	0.00%